References
- Shattock P, Savery D. Autism as a Metabolic Disorder. UK: Sunderland University Press, 1998.
- Buitelaar JK, Willemsen-Swinkels SHN. Medication treatment in subjects with autistic spectrum disorders. Eur Child Adolesc Psychiatry 2000; 9: I85 -I97.
- Hardan AY, Minshew NJ, Harenski K, Keshavan MS. Posterior fossa magnetic resonance imaging in autism. J Am Acad Child Adolesc Psychiatry 2001; 40: 666–672.
- Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML. Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 2001; 31: 537–543.
- Kemper TL, Bauman ML. Neuropathology of infantile autism. Mol Psychiatry 2002; 7: S12–S13.
- Horvath K, Perman JA. Autism and gastrointestinal symptoms. Curr Gastroenterol Report 2002; 4: 251–258.
- Shaw W. Biological Treatments for Autism and PDD. USA: W. Shaw, 1998.
- Knivsberg AM, Reichelt KL, Nodland M. Reports on dietary intervention in autistic disorders. Nutr Neurosci 2001; 4: 25–37.
- Millward C, Ferriter M, Calver S, Connell-Jones G. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev 2004; (2 ) CD003498.
- Arnold GL, Hyman SL, Mooney RA, Kirby RS. Plasma amino acids profiles in children with autism: Potential risk of nutritional deficiencies. J Autism Dev Disord 2003; 33: 449–454.
- McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 1996; 53: 993–1000.
- McDougle CJ, Naylor ST, Goodman WK, Volkmar FR, Cohen DJ, Price LH. Acute tryptophan depletion in autistic disorder: a controlled case study. Biol Psychiatry 1993; 33: 547–550.
- Vojdani A, O’Bryan T, Green JA, et al. Immune response to dietary proteins, gliadin and cerebellar peptides in children with autism. Nutr Neurosci 2004; 7: 151–161.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric Association, 1994.
- Gillberg C. Neurodevelopmental process and psychological functioning in autism. Dev Psychopathol 1999; 11: 567–587.
- Castejon HV, Ortega PA, Castejon OJ, Marcano de Hidalgo A, Monteil N, Zavala M. Imbalance of plasma amino acids in patients with autism and subjects with attention deficit/hyperactivity disorder. [abstract]. Revista Neurol 2001; 33: 401–408.
- Takahagi K, Suzuki H, Katayose K, et al. Plasma tryptophan ratio in autistic children and its change after drug therapy. Neurosciences ( Okayama) 1990; 16: 265–270.
- Shinohe A, Hashimoto K, Nakamura K, et al. Increased serum levels of glutamate in adult patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1472–1477.
- Reichelt KL, Knivsberg AM, Lind G, Nodland M. Probable etiology and possible treatment for childhood autism. Brain Dysfunct 1991; 4: 308–319.
- Pedersen OS, Liu Y, Reichelt KL. Serotonin uptake stimulating peptide found in plasma of normal individuals and in some autistic urines. J Peptide Res 1999; 53: 641–646.
- Dodd S. Understanding Autism. Sydney: Elsevier, 2005.
- Cohen B. The significance of ammonia/gamma-aminobutyric acid (GABA) ratio for normality and liver disorders. Med Hypotheses 2002; 59: 757–758.
- Kaiser-Kupfer MI, Caruso RC, Valle D. Gyrate atrophy of the choroid and retina. Longterm reduction of ornithine slows retinal degeneration. Arch Ophthalmol 1991; 109: 1539–1548.
- Panksepp J. A neurochemical theory of autism. Trends Neurosci 1979; 2: 174–177.